Skip to content
StockMarketAgent
Sector pending / Biological Products, Except Diagnostic SubstancesUpdated 2026-05-10 22:07 UTC

FRA/AB3A stock hub

FRA/AB3A has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

FRA/AB3Ais not in this month’s coverageGet our monthly research letter — no spam
Fair value midpoint
n/a
Fair value pending
Upside to midpoint
n/a
Based on latest report
Confidence
n/a
Data quality and model convergence
Market cap
1.8B
Frankfurt Stock Exchange
Market data

Price

Recent price action with selectable time range.

FRA/AB3AFRA/AB3A
—
Loading chart…
In the news

Latest news · FRA/AB3A

Recent company headlines from major financial publishers.

Loading
—
Fetching the latest headlines.
Loading
—
Fetching the latest headlines.
Loading
—
Fetching the latest headlines.
Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming
DateLoading
Window—
EPS estimate—
Revenue estimate—
Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/E8.2
P25 n/aP50 n/aP75 n/a
Trailing P/E31.7
P25 n/aP50 n/aP75 n/a
ROE4.9
P25 n/aP50 n/aP75 n/a
ROIC0.1
P25 n/aP50 n/aP75 n/a
Benchmarks - 1M
S&P 500n/a
Nasdaq Compositen/a
Dow Jones Industrial Averagen/a
Russell 2000n/a
Indicator catalog

All FRA/AB3A market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields
183
Groups with data
11
Currency
USD
Showing 183 of 183 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

18
MetricValue
Country
United States
Country code
DE
Employees
835
Employees Change
58%
Employees Change Percent
4.41
Enterprise value
EUR 2.1B
Exchange
Frankfurt Stock Exchange
Financial currency
USD
First seen
2026-05-10
Industry
Biological Products, Except Diagnostic Substances
Last refreshed
2026-05-10
Market cap
EUR 1.8B
Price
EUR 17.58
Price currency
EUR
Rev Per Employee
2,268,673.99x
Sic
2836
Symbol
fra/AB3A
Website
https://www.sarepta.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

10
MetricValue
Earnings Yield
3.15%
EV Earnings
37.65x
EV/EBITDA
12.3x
EV/FCF
21.32x
EV/Sales
1.14x
FCF yield
5.57%
Forward P/E
8.2x
P/B ratio
1.37x
P/E ratio
31.72x
P/S ratio
0.94x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

16
MetricValue
EBIT Margin
0.05%
EBITDA Margin
2.11%
FCF margin
5.26%
Gross margin
-6.49%
Gross Profit
EUR -122.9M
Gross Profit Growth Q
3.69%
Net Income
EUR 56.4M
Pretax Margin
1.12%
Profit Margin
2.98%
Profit Per Employee
EUR 67,574
ROA
0.02
Roa5y
-6.49
ROCE
0.04
ROE
4.91
Roe5y
-55.33
ROIC
0.07

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

9
MetricValue
Cagr10y
1.6%
Cagr15y
6.66%
Cagr1y
-46.43%
Cagr3y
-46.93%
Cagr5y
-22.15%
Revenue Growth
-2.2x
Revenue Growth Q
-1.89x
Revenue Growth3 Y
30.82x
Revenue Growth5 Y
30.67x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

21
MetricValue
Asset Turnover
EUR 0.66
Assets
EUR 2.8B
Cash
EUR 566.5M
Current Assets
EUR 2B
Current Liabilities
EUR 423.3M
Debt
EUR 908.1M
Debt EBITDA
EUR 5.15
Debt Equity
EUR 0.7
Debt FCF
EUR 9.11
Equity
EUR 1.3B
Interest Coverage
0.02
Liabilities
EUR 1.5B
Long Term Assets
EUR 798.4M
Long Term Liabilities
EUR 1B
Net Cash
EUR -341.6M
Net Cash By Market Cap
EUR -19.08
Net Debt EBITDA
EUR 8.53
Net Debt Equity
EUR 0.26
Net Debt FCF
EUR 3.43
Tangible Book Value
EUR 1.3B
Tangible Book Value Per Share
EUR 12.11

Liquidity

Current-asset coverage and working-capital efficiency metrics.

6
MetricValue
Current ratio
4.63
Inventory Turnover
2.39
Net Working Capital
EUR 1B
Quick ratio
2.41
Working Capital
EUR 1.6B
Working Capital Turnover
EUR 1.04

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

1
MetricValue
Buyback Yield
-10.78%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

36
MetricValue
10Y total return
17.2%
1Y total return
-46.4%
200-day SMA
16.79
3Y total return
-85.06%
50-day SMA
16.74
50-day SMA vs 200-day SMA
50under200
5Y total return
-71.41%
All Time High
160.1
All Time High Change
-89.02%
All Time High Date
2024-06-21
All Time Low
2.26
All Time Low Change
677.19%
All Time Low Date
2011-12-20
ATR
0.58
Ch YTD
-4.12
High
17.58
High52
37.9
High52 Date
2025-06-09
High52ch
-53.61%
Low
17.58
Low52
8.96
Low52 Date
2025-07-24
Low52ch
96.16%
Ma50ch
5.03%
Price vs 200-day SMA
4.73%
RSI
49.51
RSI Monthly
31.72
RSI Weekly
46.7
Sharpe ratio
-0.06x
Sortino ratio
-0.03
Total Return
-10.78%
Tr YTD
-4.12
Tr15y
163.02%
Tr1m
-9.38%
Tr1w
-2.98%
Tr3m
23.2%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

2
MetricValue
Operating Income
EUR 908,063
Operating margin
0.05

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

7
MetricValue
Float
93,469,779%
Net Borrowing
-135,146,487.6
Shares Insiders
4.12%
Shares Institutions
82.27%
Shares Qo Q
16.34%
Shares Yo Y
10.78%
Short Ratio
8.9

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

57
MetricValue
Adjusted FCF
EUR 3M
Average Volume
33.95x
Bv Per Share
12.36
CAPEX
EUR -52.4M
Ch10y
17.2
Ch15y
163
Ch1m
-9.38
Ch1w
-2.98
Ch1y
-46.4
Ch3m
23.2
Ch3y
-85.06
Ch5y
-71.41
Ch6m
16.23
Change
1.27%
Change From Open
0
Close
17.36
Days Gap
1.27
Depreciation Amortization
38,274,460.8
Earnings Date
2026-05-06
EBIT
EUR 908,063
EBITDA
EUR 40.1M
EPS
EUR 0.55
F Score
6
FCF
EUR 99.6M
FCF EV Yield
4.69x
Financing CF
-156,611,830
Fiscal Year End
December
Founded
1,980
Graham Number
12.64379
Graham Upside
-28.08
Income Tax
EUR -35.2M
Investing CF
196,381,004
Is Primary Listing
0
Last Earnings Date
2026-05-06
Last Report Date
2026-03-31
Last Split Date
2012-07-12
Last Split Type
Reverse
Ma150
17.32
Ma150ch
1.5%
Ma20
17.89
Ma20ch
-1.72%
Net CF
191,785,182
Open
17.58
P FCF Ratio
17.97
P OCF Ratio
11.77
Ppne
390,316,908.6
Price Date
2026-05-08
Price EBITDA
EUR 44.69
Ptbv Ratio
1.4
Relative Volume
71.14x
Revenue
1,894,342,783x
SBC By Revenue
5.1x
Share Based Comp
96,588,599
Tax By Revenue
-1.86x
Tr6m
16.23%
Volume
0
Z Score
0.28
Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate
n/a
Named kill scenarios are reviewed before any bullish rating can stand.
Moat score
n/a
Business quality stays separate from stock attractiveness.
Forward P/E
n/a
Valuation uses the full report model stack, not a single multiple.
Next action
Research pending
Final action steps are kept in the recommendation tab.
Income

Does FRA/AB3A pay a dividend?

Capital-return profile for this ticker.

Performance

FRA/AB3A stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

1Y total return
-46.4%
S&P 500 1Y: n/a
3Y total return
-85.1%
S&P 500 3Y: n/a
5Y total return
-71.4%
S&P 500 5Y: n/a
10Y total return
+17.2%
S&P 500 10Y: n/a
Ownership

Who owns FRA/AB3A?

Insider, institutional, and short-interest positioning.

Institutional ownership
+82.3%
Share of float held by funds and institutions
Insider ownership
+4.1%
Stake held by company insiders. Higher generally signals alignment.
Short interest
n/a
8.9 days to cover
Y/Y dilution
+10.8%
Negative means the company is buying back shares.
Technical

FRA/AB3A momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)
49.5
Neutral momentum band
Price vs 200-day MA
+4.7%
50/200-day relationship not available
Beta (5Y)
n/a
Sensitivity to the broader market
Sharpe ratio
-0.06
Risk-adjusted return — higher is better; >1.0 is solid.
Questions

About FRA/AB3A

Hub-level FAQ points readers to the deeper analysis pages.

What is the current fra/AB3A stock rating?

fra/AB3A is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full fra/AB3A analysis?

The full report lives at /stocks/fra/AB3A/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for fra/AB3A?

The latest report frames fra/AB3A around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the fra/AB3A page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.